Summit Securities Group LLC Increased Abbott Labs (ABT) Stake by $18.37 Million as Shares Rose

April 16, 2018 - By Sarah North

Abbott Laboratories (NYSE:ABT) Corporate LogoDuring Q4 2017 the big money sentiment increased to 0.91. That’s change of 0.04, from 2017Q3’s 0.87. 52 investors sold all, 558 reduced holdings as ABT ratio is positive. 430 increased holdings while 123 funds acquired holdings. Funds hold 1.22 billion shares thus 0.64% more from 2017Q3’s 1.21 billion shares. Private Harbour Investment Mngmt And Counsel Ltd Llc invested in 2.17% or 43,820 shs. Bancshares Of Montreal Can invested in 0.14% or 2.90 million shs. Duncker Streett & Communications reported 59,152 shs. 3.36 million were accumulated by Coho Ltd. Barrett Asset Mngmt Limited Liability Corp reported 115,612 shs or 0.46% of all its holdings. The New Jersey-based Groesbeck Invest Mngmt Nj has invested 1.22% in Abbott Laboratories (NYSE:ABT). Palo Cap, California-based fund reported 80,320 shs. 17,610 are owned by Inv Counselors Of Maryland Limited Company. Private Advisor Grp Ltd Com reported 107,425 shs or 0.27% of all its holdings. Bank Of Hawaii holds 0.3% of its capital in Abbott Laboratories (NYSE:ABT) for 64,882 shs. Guyasuta Invest Advisors Inc reported 20,876 shs or 0.13% of all its holdings. Hardman Johnston Global Ltd Liability holds 0.12% or 49,558 shs. Colorado-based Institute For Wealth Mgmt Limited Liability Corp has invested 0.07% in Abbott Laboratories (NYSE:ABT). Conning Incorporated owns 61,017 shs. Ifrah Services has 0.42% invested in Abbott Laboratories (NYSE:ABT) for 20,174 shs.

ABT registered $28.95 million net activity with 1 insider buy and 19 selling transactions since October 23, 2017. Funck Robert E sold $71,970 worth of Abbott Laboratories (NYSE:ABT) or 1,220 shs on Wednesday, February 28. Fussell Stephen R sold $3.36M worth of stock or 56,401 shs. On Monday, March 5 $126,559 worth of Abbott Laboratories (NYSE:ABT) was sold by Bracken Sharon J. 1,645 shs were sold by BIRD ROGER, worth $96,728. Another trade for 996 shs valued at $58,635 was made by Watkin Jared on Wednesday, February 28. MANNING JOSEPH J also sold $84,344 worth of Abbott Laboratories (NYSE:ABT) on Wednesday, February 28.

Based on the latest 2017Q4 regulatory filing with the SEC, Summit Securities Group Llc rose its stake in Abbott Labs (ABT) by 27315.25%. 322,320 shares were bought by Summit Securities Group Llc as the company’s stock rose 5.88% while stock markets declined. The major pharmaceuticals company announced $18.46 million value for the 2017Q4. Now the institutional investor is holding 323,500 shares, compared to the 1,180 from the previous quarter. Summit Securities Group Llc has cut its stake in and also reduced its holding in Kinder Morgan Inc Del (Call) (NYSE:KMI) by 32,014 shares in the quarter, for a total of 16,686 shares.

Abbott Laboratories (NYSE:ABT) Ratings Coverage

In total 15 analysts cover Abbott Labs (NYSE:ABT). “Buy” rating has 13, “Sell” are 0, while 2 are “Hold”. 87% are bullish. 26 are the (NYSE:ABT)’s analyst reports since October 18, 2017 according to StockzIntelligence Inc. On Thursday, January 25 the rating was maintained by Morgan Stanley with “Overweight”. In Thursday, October 19 report RBC Capital Markets maintained the stock with “Buy” rating. On Wednesday, January 24 the firm has “Buy” rating given by RBC Capital Markets. On Thursday, January 25 JP Morgan maintained Abbott Laboratories (NYSE:ABT) with “Overweight” rating. On Tuesday, January 2 the firm has “Overweight” rating given by Morgan Stanley. On Thursday, January 25 the stock of Abbott Laboratories (NYSE:ABT) earned “Overweight” rating by Barclays Capital. On Tuesday, January 30 the stock of Abbott Laboratories (NYSE:ABT) earned “Neutral” rating by Citigroup. On Tuesday, January 2 Guggenheim maintained Abbott Laboratories (NYSE:ABT) with “Buy” rating. On Thursday, January 25 the firm has “Buy” rating given by Guggenheim. On Tuesday, December 12 the firm has “Outperform” rating given by BMO Capital Markets.

Abbott Laboratories (NYSE:ABT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.